![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Asia Pacific Laboratory Developed Test Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Clinical Biochemistry, Critical Care, Haematology, Microbiology, Molecular Diagnostics, Immunology, and Other Test Types) and Application (Academic Institutes, Clinical Research Organizations, Hospitals Laboratory, Specialty Diagnostic Centers, and Others)
Market Introduction
A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed and used within a single laboratory. These tests can be utilized to estimate or distinguish an extensive assortment of analytes materials such as proteins, chemical compounds like glucose or cholesterol, or DNA, from a specimen received from human anatomy. The expansion of automated in vitro diagnostics (IVD) methods for labs and dispensaries to render precise, and error-free analysis is anticipated to fuel the increment.
![](https://www.theinsightpartners.com//assets/rdimages/25477-img1.jpg)
Get more information on this report :
Market Overview and Dynamics
The Asia Pacific laboratory developed test market is projected to reach US$ 4,028.17 million by 2028 from US$ 2,372.68 million in 2021; it is estimated to grow at a CAGR of 7.9% from 2021 to 2028. The key factors attributing to the market’s growth are the increasing incidence of cancer and genetic disorders and the rising automation of laboratory processes across the globe. However, the changing regulatory landscape is hampering the growth of the Asia Pacific laboratory development test market.
Automation is emerging as an approach to minimize human involvement in laboratory processes. The automation of routine laboratory procedures with the help of dedicated workstations and system software helps increase efficiency and reduce human errors. Laboratories are increasingly adopting laboratory information management systems (LIMS) and other automation tools to maintain stringent regulatory compliance, increase efficiency and productivity, and enhance data security and integrity. As per the study published in the Journal of Lab Automation, the error frequencies in fully automated, semiautomated, and manual operations are 1–5%, 1–10%, and 10–30%, respectively. Moreover, high volumes of data generated by laboratory systems are triggering the demand for effective data processing, analysis, and sharing methods, thereby highlighting the need for efficient and cost-effective solutions such as the LIMS. The automation of LDTs can significantly boost productivity and simplify compliance procedures. Clinical laboratories are under enormous pressure to manage increasing test volumes and conduct more complex diagnostic assays, further underlining the need for flexible automation systems. Many MedTech companies are offering automation solutions to help streamline clinical laboratory processes. For instance, Roche Cobas Omni–Utility Channel is beneficial for both IVD assays and high-volume LDTs. It is designed to meet the growing need for efficient workflows in laboratories, as it can assist in different stages ranging from sample processing to quick data interpretation. It can run up to 96 results in 3 hours and up to 864 results in 8 hours, thereby enhancing the efficiency of laboratories. Also, the rising incidence of cancer and growing awareness regarding the importance of early diagnostics are boosting the adoption of LDTs.
The COVID-19 outbreak has pushed diagnostics to the forefront of healthcare and increased awareness about quality testing worldwide. Many countries in Asia Pacific have taken extraordinary measures to contain the infection by ramping up the testing capacity. For instance, the new “Regulation for Medical Device Administration and Supervision,” Order 739 LDT, that allows the development of laboratory developed tests (LDT) was released in China in March 2021. This new regulation relaxes the restrictions on LDTs in China—allowing China medical institutions to develop their IVD reagents under certain conditions. Also, relaxation in government regulations regarding LDTs is further driving the market growth in the region. In addition, increasing product launches by market players are further driving the growth of the market. Hence, such developments will boost the Asia Pacific laboratory developed test market.
Key Market Segments
The Asia Pacific laboratory developed test market, by type, is segmented into clinical biochemistry, critical care, haematology, microbiology, molecular diagnostics, immunology, and other test types. The haematology segment was sub-segmented into coagulation and hemostasis, hemoglobin testing, blood count testing, and others. The molecular diagnostics segment is expected to hold the largest market share in 2021. However, the haematology segment is anticipated to register the highest CAGR during the forecast period.
The Asia Pacific laboratory developed test market, by application, is segmented into academic institutes, clinical research organizations, hospitals laboratory, specialty diagnostic centers, and others. The hospitals laboratory segment is expected to hold the largest market share in 2021. However, the specialty diagnostic centers segment is anticipated to register the highest CAGR during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources referred to while preparing the Asia Pacific laboratory developed test market report are the China Food and Drug Administration (CFDA), Ministry of Health, Labor, and Welfare (MHLW), and National Cancer Institute (NCI).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of Asia Pacific laboratory developed test market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Asia Pacific diltiazem market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific laboratory developed test market.
ASIA PACIFIC LABORATORY DEVELOPED TEST MARKET SEGMENTATION
By Type
- Clinical Biochemistry
- Critical Care
- Haematology
- Coagulation and Hemostasis,
- Hemoglobin Testing
- Blood Count Testing
- Others
- Immunology
- Microbiology
- Molecular Diagnostics
- Other Test Types
By Application
- Academic Institutes
- Clinical Research organizations
- Hospitals laboratory
- Specialty Diagnostic Centers
- Others
By Country
- India
- Japan
- China
- South Korea
- Australia
- Rest of Asia Pacific
Company Profiles
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Eurofins Scientific
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Laboratory Developed Test Market – By Type
1.3.2 Asia Pacific Laboratory Developed Test Market – By Application
1.3.3 Asia Pacific Laboratory Developed Test Market – By Country
2. Laboratory Developed Test Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Laboratory Developed Test Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Experts Opinion
5. Laboratory Developed Test Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Cancer and Genetic Disorders
5.1.2 Large Number of Product Launches
5.2 Market Restraints
5.2.1 Changing Regulatory Landscape
5.3 Market Opportunities
5.3.1 Continuous Research on Personalized Medicine
5.4 Future Trends
5.4.1 Automation of Laboratory Processes
5.5 Impact Analysis
6. Laboratory Developed Test Market –Asia Pacific Analysis
6.1 Asia Pacific Laboratory Developed Test Market Revenue Forecast and Analysis
7. Laboratory Developed Test Market Analysis – By Type
7.1 Overview
7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
7.3 Clinical Biochemistry
7.3.1 Overview
7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Haematology
7.4.1 Overview
7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Coagulation and Hemostasis
7.4.3.1 Overview
7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Hemoglobin Testing
7.4.4.1 Overview
7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Blood Count Testing
7.4.5.1 Overview
7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Immunology
7.5.1 Overview
7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Critical Care
7.6.1 Overview
7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Microbiology
7.7.1 Overview
7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Molecular Diagnostics
7.8.1 Overview
7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Other Test Types
7.9.1 Overview
7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8. Laboratory Developed Test Market Analysis – By Application
8.1 Overview
8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Clinical Research organizations
8.4.1 Overview
8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Hospital laboratory
8.5.1 Overview
8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Specialty Diagnostic Centers
8.6.1 Overview
8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
9. Laboratory Developed Test Market – Asia Pacific Analysis
9.1 Asia Pacific: Laboratory Developed Test Market
9.1.1 Overview
9.1.3 Asia Pacific: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
9.1.3.1 China: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.1 China: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1.2 China: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.1.2.1 China: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.1.3 China: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.2 Japan: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.1 Japan: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2.2 Japan: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.2.2.1 Japan: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.2.3 Japan: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.3 India: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.1 India: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.3.2 India: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.3.2.1 India: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.3.3 India: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.4 Australia: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.1 Australia: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.4.2 Australia: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.4.2.1 Australia: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.4.3 Australia: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.5 South Korea: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.1 South Korea: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.5.2 South Korea: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.5.2.1 South Korea: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.5.3 South Korea: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
9.1.3.5.4 South Korea: Laboratory Developed Test Market, by End User, 2019–2028 (USD Million)
9.1.3.6 Rest of Asia Pacific: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.1 Rest of Asia Pacific: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.6.2 Rest of Asia Pacific: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)
9.1.3.6.2.1 Rest of Asia Pacific: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)
9.1.3.6.3 Rest of Asia Pacific: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Laboratory Developed Test Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Laboratory Developed Test Market–Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F.HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 QIAGEN
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Illumina, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Eurofins Scientific
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Incidence Rate Of Cancer in 2018 in China
Table 2. China: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Laboratory Developed Test Market, By Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. India: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 9. India Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 10. India: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Australia: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Australia Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 15. South Korea Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Laboratory Developed Test Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Asia Pacific: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 21. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market
Table 22. Recent Organic Growth Strategies in the Laboratory Developed Test Market
Table 23. Glossary of Terms, Laboratory Developed Test Market
LIST OF FIGURES
Figure 1. Laboratory Developed Test Market Segmentation
Figure 2. Laboratory Developed Test Market Segmentation, By Country
Figure 3. Asia Pacific Laboratory Developed Test Market Overview
Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market
Figure 5. Asia Pacific Laboratory Developed Test Market – Leading Country Markets (US$ Million)
Figure 6. Asia Pacific PEST Analysis
Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints
Figure 2. Asia Pacific Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028
Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)
Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)
Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Asia Pacific: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Asia Pacific: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)
Figure 23. China: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Japan: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. India: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Australia: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. South Korea: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Asia Pacific: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Eurofins Scientific
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific laboratory developed test market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.